Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase i
Original languageEnglish
Pages (from-to)993-995
Number of pages3
JournalLEUKEMIA & LYMPHOMA
Volume58
DOIs
Publication statusPublished - 2017

Keywords

  • Cancer Research
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Cite this